Sign In
Buy ANIK
$14.41
+0.0300 (+0.209%)
At Close: Jun 03, 2026
Protect Your Portfolio From Volatility With 3 Low-Beta Picks
09:46am, Friday, 29'th Sep 2023
At this stage, it is prudent to invest in low-beta stocks with a favorable Zacks Rank like ALC, RDY and ANIK, as these will be less volatile than the broader market.
RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika's shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in the $1 billion1 U.S. reverse sho
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 15'th Sep 2023
BEDFORD, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September 5,
Down -20.42% in 4 Weeks, Here's Why You Should You Buy the Dip in Anika (ANIK)
11:18am, Friday, 01'st Sep 2023
The heavy selling pressure might have exhausted for Anika (ANIK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in r
All You Need to Know About Anika (ANIK) Rating Upgrade to Buy
01:32pm, Thursday, 31'st Aug 2023
Anika (ANIK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Anika (ANIK) Loses -19.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:18am, Thursday, 31'st Aug 2023
Anika (ANIK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ear
Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates
08:26pm, Tuesday, 08'th Aug 2023
Anika Therapeutics (ANIK) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.20 per share a year ago.
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
04:05pm, Thursday, 20'th Jul 2023
BEDFORD, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans
Anika Therapeutics Inc. (ANIK) Q1 2023 Earnings Call Transcript
12:23pm, Saturday, 13'th May 2023
Anika Therapeutics Inc. (NASDAQ:ANIK ) Q1 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Mark Namaroff - Executive Director of IR & Corporate Communications Cheryl Blanchard
Anika Therapeutics (ANIK) Reports Q1 Loss, Tops Revenue Estimates
08:37pm, Tuesday, 09'th May 2023
Anika Therapeutics (ANIK) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.20 per share a year ago.
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
08:30am, Wednesday, 19'th Apr 2023
BEDFORD, Mass., April 19, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plan
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Monday, 06'th Mar 2023
Anika (ANIK) delivered earnings and revenue surprises of -54.55% and 3.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?
11:17am, Tuesday, 17'th Jan 2023
Here is how Anika Therapeutics (ANIK) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year.
7 Stocks to Buy Before the Market Starts to Soar in 2023
01:24pm, Thursday, 10'th Nov 2022
With Americans being an optimistic bunch, the general assumption that the equities sector will rise following the ugly year in 2022 fundamentally bolsters several stocks to buy. However, it's importan
Anika Therapeutics (ANIK) Reports Q3 Loss, Tops Revenue Estimates
09:04pm, Tuesday, 08'th Nov 2022
Anika (ANIK) delivered earnings and revenue surprises of -20.83% and 10.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
